Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Clinical and Translational Medicine
|
November 29, 2021
An activity-based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti-fibrotic therapeutic strategies
Alison Findlay, Craig Turner, Heidi Schilter, et al.
Molecular Cancer Therapeutics
|
June 11, 2011
Enhanced efficacy of IGF1R inhibition in pediatric glioblastoma by combinatorial targeting of PDGFRα/β
Aleksandra Bielen, Lara Perryman, Gary M Box, et al.
Journal of Cellular and Molecular Medicine
|
December 12, 2018
The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis
Heidi Schilter, Alison D Findlay, Lara Perryman, et al.
Iscience
|
April 17, 2026
Matrix structure and microenvironment dynamics correlate with chemotherapy response in ovarian cancer
Florian Laforêts, Panoraia Kotantaki, Samar Elorbany, et al.
Nature
|
May 29, 2015
The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase
Thomas R Cox, Robin M H Rumney, Erwin M Schoof, et al.
Nature
|
April 17, 2023
Retraction Note: The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase
Thomas R Cox, Robin M H Rumney, Erwin M Schoof, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 25, 2012
Dependence of Wilms tumor cells on signaling through insulin-like growth factor 1 in an orthotopic xenograft model targetable by specific receptor inhibition
Aleksandra Bielen, Gary Box, Lara Perryman, et al.
Plos One
|
April 15, 2009
Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug development
Dorine A Bax, Suzanne E Little, Nathalie Gaspar, et al.
Cell
|
September 22, 2015
Kinome-wide decoding of network-attacking mutations rewiring cancer signaling
Pau Creixell, Erwin M Schoof, Craig D Simpson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 10, 2009
EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines
Dorine A Bax, Nathalie Gaspar, Suzanne E Little, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Clinical and Translational Medicine
|
November 29, 2021
An activity-based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti-fibrotic therapeutic strategies
Alison Findlay, Craig Turner, Heidi Schilter, et al.
Molecular Cancer Therapeutics
|
June 11, 2011
Enhanced efficacy of IGF1R inhibition in pediatric glioblastoma by combinatorial targeting of PDGFRα/β
Aleksandra Bielen, Lara Perryman, Gary M Box, et al.
Journal of Cellular and Molecular Medicine
|
December 12, 2018
The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis
Heidi Schilter, Alison D Findlay, Lara Perryman, et al.
Iscience
|
April 17, 2026
Matrix structure and microenvironment dynamics correlate with chemotherapy response in ovarian cancer
Florian Laforêts, Panoraia Kotantaki, Samar Elorbany, et al.
Nature
|
May 29, 2015
The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase
Thomas R Cox, Robin M H Rumney, Erwin M Schoof, et al.
Nature
|
April 17, 2023
Retraction Note: The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase
Thomas R Cox, Robin M H Rumney, Erwin M Schoof, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 25, 2012
Dependence of Wilms tumor cells on signaling through insulin-like growth factor 1 in an orthotopic xenograft model targetable by specific receptor inhibition
Aleksandra Bielen, Gary Box, Lara Perryman, et al.
Plos One
|
April 15, 2009
Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug development
Dorine A Bax, Suzanne E Little, Nathalie Gaspar, et al.
Cell
|
September 22, 2015
Kinome-wide decoding of network-attacking mutations rewiring cancer signaling
Pau Creixell, Erwin M Schoof, Craig D Simpson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 10, 2009
EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines
Dorine A Bax, Nathalie Gaspar, Suzanne E Little, et al.
Page
of 3